C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2002
10/24/2002	WO1999050288A3 Mammalian blood loss-induced gene, kd312
10/24/2002	US20020157127 Transgene that comprises DNA encoding for epitope tagged TATA box binding protein (TBP), production of transgenic animals which express epitope-tagged TBP and use of epitope tagged TBP for isolating and affinity purifying transcription factors
10/24/2002	US20020157125 Growth differentiation factor-8
10/24/2002	US20020157122 Beta-secretase transgenic organisms, anti-beta-secretase antibodies, and methods of use thereof
10/24/2002	US20020156266 Sodium phosphate cotransporter expressed on apical surface of intestinal epithelial cells (huNpt2B) and polypeptides related thereto
10/24/2002	US20020156264 And method of using the carboxypeptidase polypeptides and polynucleotides as a target for diagnosis and treatment in carboxypeptidase-related disorders
10/24/2002	US20020156258 Transcription factor of MHC class II genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
10/24/2002	US20020156252 Novel Stra6 polypeptides
10/24/2002	US20020156248 Novel method for targeted delivery of nucleic acids
10/24/2002	US20020156247 Mammalian checkpoint genes and proteins
10/24/2002	US20020156244 Adipocyte complement related protein zacrp13
10/24/2002	US20020156243 Adipocyte-specific protein homologs
10/24/2002	US20020156036 Expression vector encoding a fusion protein with segments of a region which binds to an epitope or fragment and fragment or whole proteins that can cross the blood brain barrier
10/24/2002	US20020156035 NET-4 is a member of the tetraspan transmembrane receptor family; antisense molecules, ribozymes, antibodies and antibody fragments for reductin NET-4 gene expression or activity; antitumor agents
10/24/2002	US20020156031 A DNA segment comprising a protein coding region encoding an Osterix polypeptide; gene therapy; osteoporosis; recombinant Osterix polypeptide
10/24/2002	US20020156013 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
10/24/2002	US20020156006 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/24/2002	US20020156001 Novel fibroblast growth factor ( FGF23) and methods for use
10/24/2002	US20020155987 Isolated endostatin, especially approximately 20 kDa and corresponds to a C-terminal fragment of collagen type XVIII
10/24/2002	US20020155972 Detergent compositions comprising benefit agents
10/24/2002	US20020155968 Granulated with an alkali metal salt; used in an enzymatic stain bleaching or anti dye-transfer composition.
10/24/2002	US20020155604 Compositions and methods for regulating lymphocyte activation
10/24/2002	US20020155577 Compound for use in the treatment of parkinson's disease
10/24/2002	US20020155572 Peptide for use in diagnosis and treatment of alzheimier's disease
10/24/2002	US20020155552 "prionins", highly specific markers for noninvasive pre-symptomatic detection of tse diseases, and targets for therapeutic reagents to prevent and control tse diseases in animals and humans
10/24/2002	US20020155545 Chemokines expressed in pancreas
10/24/2002	US20020155539 Calcium channel polynucleotides, polypeptides, and antibodies
10/24/2002	US20020155537 Method for making heteromultimeric polypeptides
10/24/2002	US20020155534 SBHWSB2: a new member of the WD40 SOCS box family
10/24/2002	US20020155531 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
10/24/2002	US20020155527 Nucleotide sequences coding membrane protein for use in the treatment of tumors
10/24/2002	US20020155511 Novel antibody compositions for the negative selection of specific rat leukocyte subsets
10/24/2002	US20020155510 Dendritic cell-specific antibodies
10/24/2002	US20020155506 Human IL-1 epsilon DNA and polypeptides
10/24/2002	US20020155498 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
10/24/2002	US20020155453 Method for generating diversity
10/24/2002	US20020155447 Nucleotide sequences coding polypeptide for use in the treatment of cancer
10/24/2002	US20020155441 Polypeptides for use in the, detection, prevention, treatment and diagnosis of malarial infection
10/24/2002	US20020155437 Detecting cancer cells in sample; obtain cells, detect preferential gene expression product, presence of expression product indicates cancer
10/24/2002	US20020155433 Polypeptide for use the prevention of infections associated with tissue grafting
10/24/2002	US20020155121 Virus coat protein/receptor chimeras and methods of use
10/24/2002	US20020155115 Cancer therapy
10/24/2002	US20020155114 Useful in therapy of botulism
10/24/2002	US20020155113 Methods for treating or preventing cardiovascular disorders by modulating metalloprotease function
10/24/2002	US20020155110 Soluble mast cell function associated antigen (MAFA) pharmaceutical compositions and methods of making and using them
10/24/2002	US20020155109 Antibodies that induce apoptosis of tumor cells and virally infected cells are used in therapy of cancer and viral infections
10/24/2002	US20020155105 Administering to therapeutic formulation comprising peptides having sequence identity with ribosomal protein S1 which are immunoreactive with anti-dsDNA and anti-idiotypic antibody or antibody fragments immunoreactive with anti-dsDNA antibodies
10/24/2002	DE10119804A1 New peptides produced in primates during inflammation and sepsis, useful for diagnosis and treatment of these diseases, and their related antibodies
10/24/2002	CA2445990A1 Full-length human cdnas encoding potentially secreted proteins
10/24/2002	CA2444632A1 Vascular endothelial growth factor 2
10/24/2002	CA2444624A1 Vascular endothelial growth factor 2
10/24/2002	CA2444298A1 Method for enhancing the translation and expression of recombinant proteins
10/24/2002	CA2444262A1 Bifunctional energy-reversible acyl-compositions
10/24/2002	CA2444133A1 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
10/24/2002	CA2444047A1 Methods to inhibit viral replication
10/24/2002	CA2443995A1 Endothelial cell expression patterns
10/24/2002	CA2443903A1 Antibodies to vla-1
10/24/2002	CA2443897A1 Transporters and ion channels
10/24/2002	CA2443874A1 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
10/24/2002	CA2443862A1 Structure-based construction of human antibody library
10/24/2002	CA2443705A1 Cyclic single strand trispecific antibody
10/24/2002	CA2443525A1 Human cellular protein gastrointestinal glutathione peroxidase as target for medical intervention against hepatitis c virus infections
10/24/2002	CA2443493A1 Surface proteins of streptococcus pyogenes
10/24/2002	CA2443408A1 Kinases and phosphatases
10/24/2002	CA2443244A1 Enzymes
10/24/2002	CA2443147A1 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
10/24/2002	CA2443141A1 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
10/24/2002	CA2443123A1 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
10/24/2002	CA2443088A1 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
10/24/2002	CA2442367A1 Method for detecting multiple dna binding protein and dna interactions in a sample, and devices, systems and kits for practicing the same
10/24/2002	CA2438107A1 G-protein coupled receptor molecules and uses thereof
10/23/2002	EP1251177A2 Cytokine-, stress-, and oncoprotein-activited human protein kinase kinases
10/23/2002	EP1251176A2 Expression systems utilizing autolyzing fusion proteins and a reducing polypeptide
10/23/2002	EP1251173A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2002	EP1251139A2 Human mindin-like protein and nucleic acids encoding it
10/23/2002	EP1251137A2 Use of insulin-like growth factor agonist peptides
10/23/2002	EP1250443A2 ANTI-CD3 SINGLE-CHAIN ANTIBODIES HAVING HUMAN C $g(m)?3 AND C $g(m)?4 DOMAINS
10/23/2002	EP1250437A2 Membrane-bound proteins and nucleic acids encoding the same
10/23/2002	EP1250434A2 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
10/23/2002	EP1250432A2 Nuclear hormone receptors
10/23/2002	EP1250429A2 Human sperm specific lysozyme-like proteins
10/23/2002	EP1250426A2 Secreted and transmembrane polypeptides and nucleic acids encoding same
10/23/2002	EP1250425A2 Secreted human proteins, polynucleotides encoding them and methods of using the same
10/23/2002	EP1250354A1 Peptide fragments of colostrinin and their use
10/23/2002	EP1250352A1 Receptor-like protein kinases from nicotiana tabacum
10/23/2002	EP1250149A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer
10/23/2002	EP1250055A1 Immune modulation with death receptor-induced apoptosis
10/23/2002	EP0920449B1 Morbillivirus-derived peptides
10/23/2002	EP0909278A4 Nephropathy-related immunoglobulin g and antibodies for same
10/23/2002	EP0766745B1 Monoclonal antibody specific for human 4-1bb and cell line producing same
10/23/2002	EP0750510B1 Anti-acne skin treatment composition
10/23/2002	EP0721470B1 Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer
10/23/2002	EP0642581B1 Clostridium perfringens vaccines
10/23/2002	EP0576623B1 Binding domains in notch and delta proteins
10/23/2002	CN1376196A Method for generating immune-compatible cells and tissues using nuclear transfer techniques
10/23/2002	CN1376163A Highly purified cytokine activating factor and methods of use
10/23/2002	CN1375505A Genetically engineering monoclonal anti-digoxin single-stranded antibody and its use
10/23/2002	CN1375501A New osteoclast formation inhibiting factor and its coding sequence and use
10/23/2002	CN1092979C Process for preparing multi-strain antibody from water fowls
10/22/2002	US6469230 Starch debranching enzymes

1 ... 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 ... 1494